Drug Shortage Report for APO AMPI LIQ 250MG/5ML
| Report ID | 19586 |
| Drug Identification Number | 00603287 |
| Brand name | APO AMPI LIQ 250MG/5ML |
| Common or Proper name | AMPICILLIN |
| Company Name | APOTEX INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | AMPICILLIN |
| Strength(s) | 250MG |
| Dosage form(s) | LIQUID |
| Route of administration | ORAL |
| Packaging size | 60/100/150 ML |
| ATC code | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-03-10 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2017-10-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-08-16 | English | Compare |
| v2 | 2017-08-16 | French | Compare |
Showing 1 to 2 of 2